Despite a 28% decline in sales to $404 million, the company witnessed stabilization in commercial volumes and strong government business performance. Aviation Services grew 6% sequentially, driven by increased MRO business and government strength. Adjusted operating margins improved to 4% due to cost-cutting measures and restructuring. Notably, the company secured significant new business contracts valued at $1.7 billion, positioning it for growth. The company's balance sheet remains strong with low net leverage and ample liquidity, enabling it to pursue more opportunities. As vaccines roll out, the company anticipates a recovery in travel and continued focus on cash flow, margin improvement, and new business acquisition.